Business · 21 October 2026
OpenAI acquires Orchestra Bio to build out biotech business
OpenAI bought AI biotech software startup Orchestra Bio to support its life-sciences work around its Rosalind model; terms undisclosed.
Why it matters
Labs are moving into vertical products, so reassess where horizontal AI startups can still win.
For product managers
For your product
What does this mean for your product?
Try it on your product More from this issue
Get this every morning, written for your product.
Deltaday reads the whole AI news cycle and tells you what changed, whether it's real yet, and what to do about it.